Related Experiment Video
Updated: Jul 13, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Rapid diagnostic testing for mycobacterial infections.
1Cleveland Clinic, Infectious Diseases/S-32, Cleveland, OH 44195, USA. shrestn@ccf.org
Future Microbiology
|August 9, 2007
Summary
Nucleic acid amplification tests offer rapid detection of mycobacteria, potentially revolutionizing diagnosis. Interferon-gamma release assays are also emerging as faster alternatives to traditional skin tests for mycobacterial diseases.
Area of Science:
- Microbiology
- Infectious Diseases
- Molecular Diagnostics
Background:
- Mycobacterial diseases pose significant diagnostic challenges.
- Current diagnostic methods can be slow and lack specificity.
- Rapid and accurate detection is crucial for effective treatment.
Purpose of the Study:
- To evaluate nucleic acid amplification tests (NAATs) for rapid mycobacteria detection.
- To explore genotypic methods for species identification and antimicrobial resistance.
- To assess the potential of IFN-gamma-based assays as alternatives to skin tests.
Main Methods:
- Nucleic acid amplification, hybridization, and DNA sequencing were utilized.
- Combined NAATs with genotypic identification for direct sample analysis.
- IFN-gamma release assays were compared to tuberculin skin tests.
Main Results:
- NAATs enable rapid detection and identification of mycobacteria in clinical samples.
- Genotypic methods allow species-level identification and resistance mutation detection.
- IFN-gamma assays provide faster results than tuberculin skin tests.
Conclusions:
- NAATs and genotypic methods show promise for revolutionizing mycobacterial disease diagnosis.
- These molecular techniques facilitate direct detection, identification, and antimicrobial resistance profiling.
- IFN-gamma assays are poised to replace tuberculin skin tests due to speed and improved performance.
Related Concept Videos
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
